CYLD and neoplasm: The study demonstrated that as early as second round of DSS treatment, the CYLD−/− mice developed multiple measurable broad-based adenocarcinomas (i.e. flattened, or called sessile) in the colonic epithelium, as compared to almost no tumor in the CYLD+/+ mice.